For cats not suitable for radioiodine therapy or surgery, medical management of hyperthyroidism with methimazole provides effective welfare improvement when well managed.
Medical management of feline hyperthyroidism represents an important welfare option for cats where radioiodine or surgery is not accessible or appropriate. While not curative, effective methimazole control normalizes thyroid hormone levels and reverses the catabolic, cardiovascular, and hypertensive consequences of hyperthyroidism, substantially improving quality of life. The welfare cost of daily medication must be honestly assessed: some cats tolerate transdermal gel application well, while others experience significant stress from repeated handling. Owners who struggle to medicate their cats often under-dose or skip doses, leading to poor control that allows hyperthyroid welfare consequences to persist. Regular monitoring of thyroid levels, kidney function, and blood pressure allows dose adjustments that maintain control while minimizing side effects.